U.S. FDA approves first nonprescription daily oral contraceptive


  • World
  • Friday, 14 Jul 2023

LOS ANGELES, July 13 (Xinhua) -- The U.S. Food and Drug Administration (FDA) on Thursday approved Opill (norgestrel) tablet for nonprescription use to prevent pregnancy, which is the first daily oral contraceptive approved for use in the United States without a prescription.

Approval of this progestin-only oral contraceptive pill provides an option for consumers to purchase oral contraceptive medicine without a prescription at drug stores, convenience stores and grocery stores, as well as online.

Save 30% OFF The Star Digital Access

Monthly Plan

RM 13.90/month

RM 9.73/month

Billed as RM 9.73 for the 1st month, RM 13.90 thereafter.

Best Value

Annual Plan

RM 12.33/month

RM 8.63/month

Billed as RM 103.60 for the 1st year, RM 148 thereafter.

Follow us on our official WhatsApp channel for breaking news alerts and key updates!

Next In World

US Official says Washington is open for business if Iran wishes to contact them
Trump says he is raising tariffs on South Korean imports
Urgent: Trump announces increasing tariffs on certain South Korean products from 15 pct to 25 pct
At least 8 killed in 4 armed attacks in Ecuador
Trump's immigration approval drops to record low, Reuters/Ipsos poll finds
U.S. stocks close higher
Hungary to take diplomatic steps over Ukrainian remarks, election interference concerns
Portugal launches digital business wallet to cut red tape, boost competitiveness
Crude futures settle lower
U.S. dollar ticks down

Others Also Read